This is definitely part of the solution. It’s a regulatory problem as much as anything else. I can’t even fathom how many drugs didn’t make it to market because of how hard it is even to get a great one across the finish line.

I think a lot of it comes back to the Hippocratic principle of first do no harm, which sounds lovely, but mathematically speaking is an obvious disaster in instances like this.